Latest filing published 10 Dec 2025 for Adverum Biotechnologies, Inc..
Not enough history yet: 0 closed purchases, at least 2 are needed.
Linda M. Rubinstein is a declared insider at 2 companies; the most frequent names are Solexa, Inc. and Adverum Biotechnologies, Inc. The record holds 21 filings, for trades running from 13 December 2006 to 9 December 2025.
On the open market, the record shows 1 purchase worth €136k and 7 sales worth €864k. The net balance comes to €728k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants and 8 option exercises.
Most recently, on 10 December 2025, the filings show a transaction in Adverum Biotechnologies, Inc. The clock since the last published purchase (9 June 2023) now reads 1,233 days. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations